The eatertainment brand saw same-store sales fall 7.7% last quarter, and failed to maintain a leverage ratio required by a financing covenant.
In a report released today, Mark Massaro from BTIG reiterated a Buy rating on Guardant Health (GH – Research Report), with a price target of ...
BTIG analyst Marie Thibault raised the firm’s price target on iRhythm (IRTC) to $135 from $120 and keeps a Buy rating on the shares after its ...